Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DAVID V GOEDDEL Insider Profile
32 Followers
DAVID V GOEDDEL, Director, Ten Percent Owner at NGM Biopharmaceuticals, holds 1.00K shares in NGM Biopharmaceuticals (Ticker: NGM), holds 23.00M shares in Tenaya Therapeutics (Ticker: TNYA), holds 6.78M shares in RAPT Therapeutics (Ticker: RAPT).
DAVID V GOEDDEL NGM Biopharmaceuticals (NGM)Director, Ten Percent Owner
NGM Biopharmaceuticals (NGM)
Director, Ten Percent Owner
Ranked #5,103 out of 99,335 Corporate Insiders
Profitable Transactions
36 out of 60 Profitable Transactions
Average Return
+9.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that DAVID V GOEDDEL holds in companies
Most Profitable Insider Trade
The most profitable trade made by DAVID V GOEDDEL
DAVID V GOEDDEL's Trading History
NGM Biopharmaceuticals
Apr 08, 2024
―
Uninformative Sell
―
$1.54K
RAPT Therapeutics
Nov 04, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$7.12M
Tenaya Therapeutics
Feb 14, 2024
Director, Ten Percent Owner
Informative Buy
10.00M
$49.68M
List of latest transactions for each holding click on a transaction to see DAVID V GOEDDEL's performance on stock
You May Also Like
DAVID V GOEDDEL insider profile FAQ
What is the percentage of profitable transactions made by DAVID V GOEDDEL?
The percentage of profitable transactions made by DAVID V GOEDDEL is 60%.
What is the average return per transaction made by DAVID V GOEDDEL?
The average return per transaction made by DAVID V GOEDDEL is 9.00%.
What stocks does DAVID V GOEDDEL hold?
DAVID V GOEDDEL holds: NGM, RAPT, TNYA stocks.
What was DAVID V GOEDDEL’s latest transaction?
DAVID V GOEDDEL latest transaction was an Uninformative Sell of ―.
What was DAVID V GOEDDEL's most profitable transaction?
DAVID V GOEDDEL’s most profitable transaction was an Informative Buy of RAPT stock on November 4, 2019. The return on the trade was 155.60%.
What is DAVID V GOEDDEL's role in NGM Biopharmaceuticals?
DAVID V GOEDDEL's role in NGM Biopharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.